Danaher Gross Profit decreased by 9.5% to $3.59B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.3%, from $3.51B to $3.59B. Over 4 years (FY 2021 to FY 2025), Gross Profit shows relatively stable performance with a -1.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests improved production efficiency or higher pricing power, while a decrease may indicate rising input costs or competitive pricing pressure.
Gross profit represents the residual profit earned by a company after deducting the direct costs associated with produci...
Peers in the life sciences and diagnostics sector typically maintain high gross margins due to the specialized nature of their instruments and recurring revenue from consumables.
gross_profit| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.40B | $4.36B | $2.23B | $3.54B | $3.50B | $3.38B | $4.23B | $3.66B | $3.32B | $3.28B | $3.78B | $3.49B | $3.43B | $3.40B | $3.89B | $3.51B | $3.52B | $3.52B | $3.97B | $3.59B |
| QoQ Change | — | -0.9% | -48.8% | +58.9% | -1.3% | -3.5% | +25.2% | -13.3% | -9.4% | -1.3% | +15.4% | -7.7% | -1.7% | -0.8% | +14.4% | -9.7% | +0.3% | +0.0% | +12.6% | -9.5% |
| YoY Change | — | — | — | — | -20.4% | -22.6% | +89.5% | +3.4% | -5.1% | -3.0% | -10.6% | -4.8% | +3.3% | +3.8% | +2.9% | +0.7% | +2.8% | +3.6% | +2.0% | +2.3% |